$V
Q2 20 
-Non-GAAP EPS $1.39 beat by $0.04
-GAAP EPS $1.38 beat by $0.03.
-Rev +6.6% Y/Y beat by $100M.
-CV19 outbreak slowed the quarter. Significant declines in March
-Returned $3.9B of capital to shareholders in share repurchases &amp; dividends

**Good. No adj.until nxt ER**